The Department of Urologic Surgery at the University of Oklahoma College of Medicine provides world class patient care by nationally recognized experts in the field of Urology. We have expertise in all subspecialties within the field of urology and offer a comprehensive approach to patient care incorporating cutting edge diagnostic and treatment modalities. We have a comprehensive residency and fellowship training program and strive to train leaders in the field of urology. In collaboration with our research scientists we strive to develop innovative treatment options to patients suffering from urologic disease.
BCG-unresponsive NMIBC: Advancements are finally moving the needle
February 1st 2024"I predict 2024 will be a banner year for progress in the management of [NMIBC], and not only will we be moving the needle but also turning up the volume in this historically quiet space," writes Michael S. Cookson, MD, MMHC, FACS.
Updates on advanced bladder cancer treatment
October 30th 2023"If a patient begins treatment with platinum-based chemotherapy and maintenance immune checkpoint inhibition, second-line options may involve evaluating erdafitinib, ADCs, or participation in clinical trials," says Adanma Ayanambakkam, MD.
Prostate cancer treatment deintensification: When less is more
August 16th 2023"Despite challenges, ongoing research and advancements in risk stratification, imaging techniques, and targeted therapies are paving the way for personalized and precision medicine approaches in prostate cancer management," writes Michael S. Cookson, MD, MMHC, FACS.
Artificial intelligence in life, medicine, and urology: The future is here
March 6th 2023"AI has...been increasingly utilized in the field of medicine, including cancer research, because of its potential to improve diagnostic accuracy, prognosis prediction, and personalized treatment planning," writes Michael S. Cookson, MD, MMHC.
Dr. Cookson highlights results of PROpel trial for mCRPC
February 20th 2023"This trial did not require a biomarker for entry in, so patients were treated with combination therapy or standard care, which would have been the abiraterone alone, to see if there was a benefit," says Michael S. Cookson, MD, MMHC.
Pushing past the pandemic’s impact on prostate cancer screening
September 26th 2022"Cancer doesn’t take a holiday or vacation, and it doesn’t care about a pandemic. Our efforts to reduce deaths from prostate cancer through screening and early detection must continue," writes Michael S. Cookson, MD, MMHC.
Urology Times 50 Innovations Series: Blue light cystoscopy for the detection of bladder cancer
July 13th 2022“There are numerous trials that say that if you use blue light cystoscopy, in about 25% of patients, it will help you pick up a tumor you otherwise would have missed with traditional white light cystoscopy,” says Sanjay Patel, MD.
Marking 5 decades of progress in cancer care
January 4th 2022"As we celebrate the tremendous victories against cancer and commemorate 5 decades of progress, we are also reminded of the harsh reality that we have a war still to be won," writes Michael S. Cookson, MD, MMHC, co–editor in chief of Urology Times.